Precision Medicine, CRISPR, and Genome Engineering Moving from Association to Biology and Therapeutics

(Dana P.) #1

104


is characterized by a particular set of activities or sequences that lead up to the


interference of the foreign viral particle. In the adaptation phase, the infection is


recognized and potential spacer sequences are identified and are inserted within the


genome. In the expression phase, the CRISPR locus is transcribed into a precursor


RNA (pre-crRNA). The adjacent cas genes are transcribed to form the Cas proteins,


which then cleave the pre-crRNA to a mature crRNA. In the final interference stage, the


mature crRNA acts in concert with a few of the expressed Cas proteins. It recog-


nizes the target nucleic acid region and destabilizes it. Thus, in its entirety, this


process grants immunity to prokaryotes.


CRISPR adaptation is the first stage or phase of the entire process and is impor-

tant as it provides memory of a prior infection and thus helps in the expression and


interference phases that come in later. Adaptation involves spacer acquisition, which


is not completely understood yet. It is apparent that two of the conserved Cas pro-


teins, Cas1 and Cas2, play an important role in identifying and acquiring spacers


into the CRISPR array for subsequent steps of expression and interference against


the phage-virus attacking the prokaryotic genome. This entire process can be whit-


tled down to two levels, selection of the protospacer and subsequent generation of


the spacer, and that is succeeded by integration of the spacer into the CRISPR array


Fig. 6.1 The steps involved in the adaptive immunity in bacteria and archaea that is achieved with
the help of the CRISPR-Cas system. It involves three phases or stages: adaptation, expression, and
interference


A. Bandyopadhyay et al.
Free download pdf